BioTuesdays

QT Imaging Announces Plans to Relist on Nasdaq

QT Imaging Logo

QT Imaging (OTCQB: QTIH) has announced that it has submitted its application to relist on the Nasdaq Capital Market. In connection with this planned relisting, the company also announced that its Board of Directors has approved a 3:1 reverse stock split, which is intended to fulfill the requirement that the Company’s common stock must be $4.00 or higher at the time of listing on Nasdaq.

At its annual meeting held in August, the QTI’s stockholders approved the reverse stock split. The Board of Directors was authorized to implement the reverse stock split and fix the ratio of the split within a range of 2:1 to 20:1. On October 17, 2025, the Board of Directors determined to fix the ratio for the reverse stock split at 3:1. The reverse stock split will become effective at 4:01 p.m. EDT on October 23, 2025, after close of trading, and the shares of common stock will begin trading on a split-adjusted basis on the OTCQB under the existing trading symbol “QTIH” on October 24, 2025. The new CUSIP number for the Company’s common stock following the reverse stock split will be 746962307.

In a statement, Dr. Raluca Dinu, CEO of QTI, commented, “Our application to relist on Nasdaq less than a year after leaving the exchange, coupled with a conservative reverse stock split ratio, is a testament to the exciting momentum and strong growth trajectory in our business. Moving back to a national exchange represents a significant step toward creating long-term stockholder value and attracting a broader, more diverse stockholder base.”

POWERED BY

Stay Ahead in Healthcare & Life Sciences